Halaman 4 - Radioterapi Dokter Terbaik - TOP-74 dokter

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

Profesor Ari Rafael — direktur layanan Onkologi Translasional dan peneliti di departemen penelitian klinis kanker di Pusat Medis Suraski (Ichilov, Tel Aviv). Pasien menghargai pendekatannya yang individual dan perhatian terhadap kebutuhan setiap individu.

Kualifikasi dan nilai bagi pasien:

• Memimpin rumah sakit onkologi siang hari dan mengarahkan proyek-proyek kedokteran genom nasional. Hal ini memastikan akses ke penelitian terkini.

• Bekerja sebagai penyelidik sub-utama dan penyelidik utama dalam banyak uji klinis fase I–III, termasuk suntikan intratumoral mRNA dan obat-obatan virus. Pasien mendapatkan kesempatan untuk berpartisipasi dalam metode pengobatan inovatif.

• Memiliki pengalaman internasional di AS dan Inggris — menjamin penerapan standar dunia dan protokol canggih.

• Anggota organisasi internasional (ESMO, IASLC, ISLB, ISCORT, Asosiasi Medis Israel). Menggunakan standar pengobatan modern dan berpartisipasi dalam penelitian global.

• Secara rutin meningkatkan kualifikasi dan mengikuti pelatihan sesuai standar praktik klinis internasional, termasuk ICH GCP R2, Panduan MOH Israel, serta kursus terbaru tentang persetujuan yang diinformasikan, penanganan efek samping, dan keselamatan pasien.

Pasien menghargai Profesor Rafael atas pilihan rencana pengobatan yang tepat, penerapan inovasi, dan perhatian yang mendetail, yang memberikan rasa percaya dan aman pada setiap tahap terapi.

Pendidikan :

Universitas Istanbul, Fakultas Kedokteran Istanbul, September 2004 – Juli 2010

Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Ortopedi, Residen Februari 2011 - April 2011

Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Oftalmologi, Residen Agustus 2011 - Maret 2016

Universitas Thomas Jefferson, Wills Eye Institute, Departemen Onkologi Okular, Pengamatan Agustus 2012 - September 2012

Kementerian Kesehatan Turki, Rumah Sakit Negara Hakkari, Klinik Oftalmologi, Dokter Spesialis Mata Juli 2016 – Maret 2018

Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Asisten Profesor, Maret 2018 – Oktober 2021

Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Oktober 2021 – Desember 2021

Universitas Istanbul Yeni Yuzyil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Januari 2022 – sekarang

Kualifikasi Pendidikan :

1. Penilaian ilmu dasar oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2017

2. Ujian Optik & Refraksi International Council of Ophthalmology (ICO) lulus pada April 2017

3. Ujian Ilmu Klinis dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2018

4. Menerima beasiswa ICO-STAAR Bedah Tiga Bulan dalam Vitreo-Retina di University of Kansas, Fakultas Kedokteran, Departemen Oftalmologi di Prairie Village, KS, Amerika Serikat di bawah pengawasan Prof. Radwan Aijlan dari 6 April 2020 hingga 5 Juli 2020.

5. Ujian Lanjutan dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada Juli 2020.

6. United States Medical Licensing Examination (USMLE) Step 1 lulus pada 7 Januari 2021 dengan 221 poin.

7. United States Medical Licensing Examination (USMLE) Step 2 CK lulus pada 25 Agustus 2021 dengan 214 poin.

Presentasi & Poster :

1. Kongres Oftalmologi Nasional ke-47, Efektivitas terapi fotodinamik pada hemangioma koroid sirkumsirkum, Presentasi lisan, Ozer MD, Tuncer S, November 2013, Antalya, Turki.

2. Kongres Oftalmologi Nasional ke-48, Fitur klinis dan hasil pengobatan rhabdomyosarcoma oftalmik primer: Pengalaman pusat tersier, Ozer MD, Ulas MG, Tuncer S, Presentasi lisan, November 2014, Antalya, Turki

3. Pertemuan ISOO 2015, Hasil Jangka Panjang Terapi Kombinasi (Suntikan Perilesional dan Topikal) Interferon Alpha-2b dalam Manajemen Neoplasia Skuamosa Permukaan Mata, Tuncer S, Ozer MD, Presentasi lisan, Juni 2015, Paris, Prancis

4. Kongres Oftalmologi Nasional ke-49. Pola presentasi klinis sindrom Vogt-Koyanagi-Harada pediatrik dan hasil tindak lanjut jangka panjang, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Presentasi lisan, November 2015, Istanbul, Turki.

5. Kongres Oftalmologi Nasional ke-49, Ketebalan kornea sentral dan dimensi cakram optik pada pasien glaukoma, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turki.

6. Kongres Oftalmologi Nasional ke-49, Analisis lapisan serat saraf retina dan ketebalan koroid pada pasien dengan sklerosis sistemik untuk mengidentifikasi faktor risiko potensial untuk glaukoma tekanan normal, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turki.

7. Kongres Oftalmologi Nasional ke-50, Pengobatan degenerasi makula terkait usia dengan Ranibizumab intravitreal: Pengalaman kehidupan nyata, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Presentasi lisan, November 2016, Antalya, Turki

8. Kongres Oftalmologi Nasional ke-51, Komplikasi jarang terlihat dari operasi katarak: Hematoma Endokapsular, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turki

9. Kongres Oftalmologi Nasional ke-52, Nanophthalmos dengan Lipatan Makula, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

10. Kongres Oftalmologi Nasional ke-52, Fitur Klinis dan Metode Pengobatan Kasus Selulitis Orbital, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

11. Kongres Oftalmologi Nasional ke-52, Seri Kasus: Luka Bakar Kimia Mata, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turki

12. Kongres Oftalmologi Nasional ke-52, Kehilangan Pendengaran Sensorineural yang Mempengaruhi Frekuensi Rendah pada Pasien dengan Pseudoeksfoliasi, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turki

13. Kongres Oftalmologi Nasional ke-52, Intubasi tabung silikon oleh stent Ritleng pada anak-anak di atas dua tahun dengan obstruksi saluran nasolakrimal, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turki

14. Kongres Oftalmologi Nasional ke-52, Tampilan Bintik Merah Ceri di Makula dan Alkaptonuria: Laporan Kasus, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

15. Kongres Oftalmologi Nasional ke-52, Komplikasi Langka pada Implantasi Deksametason Intravitreal: Migrasi Implan ke Ruang Anterior, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

16. Kongres Oftalmologi Nasional ke-52, Efek Tetes Mata Koenzim Q10 pada Penyembuhan Luka Kornea dalam Pengobatan Keratitis Bakteri, Batur M, Seven E, Tekin S, Ozer MD, Presentasi lisan, November 2018, Antalya, Turki

17. Kongres Euretina ke-19, Efek produksi humor aquous yang berkurang pada potensi pertumbuhan bakteri di mata kelinci, Batur M, Ozer M, Tekin S, Presentasi lisan, September 2019, Paris, Prancis

18. Kongres Oftalmologi Nasional ke-53, Evaluasi fitur klinis pasien dengan hifema akibat trauma tumpul, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Presentasi lisan, November 2019, Antalya, Turki

19. Kongres Oftalmologi Nasional ke-53, Kepatuhan terhadap terapi tetes mata dan hubungan kepatuhan dengan perkembangan pada pasien glaukoma, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turki

20. Kongres Oftalmologi Nasional ke-53, Kehilangan penglihatan bilateral mendadak-sementara setelah pelepasan kateter venosa sentral, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

21. Kongres Oftalmologi Nasional ke-53, Evaluasi klinis terapi fotokoagulasi laser Argon pada pasien dengan robekan retina, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

22. Kongres Oftalmologi Nasional ke-53, Kerusakan makula akibat epilasi laser: laporan kasus, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turki

23. Kongres Oftalmologi Nasional ke-53, Makulopati Fototoksik akibat Penggunaan Berlebihan Inframerah Iluminator Bersama Scope Penglihatan Malam Tangan, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turki

24. Kongres Oftalmologi Nasional ke-54, Ophthalmoplegia internal setelah infeksi cacar air, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turki.

Pengalaman Kerja :

1. Studi Tahap II untuk Menganalisis Sarilumab dalam Uveitis Non-Infeksius (SARILNIUSATURN-Sanofi), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

2. Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-A&C-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

3. Studi Acak, Tertutup Ganda, Dikendalikan Plasebo tentang Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-B-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

4. Studi 12 bulan, acak, tertutup ganda, dikendalikan semu, multicenter untuk mengevaluasi efikasi dan keamanan injeksi intravitreal ranibizumab 0,5 mg akibat edema makula akibat faktor pertumbuhan endotel vaskular (VEGF) (RFB002-Novartis), Peneliti sub-injeksi (Peneliti Utama: Prof. Dr. Nur Kir)

5. Studi fase III multicenter, acak, tertutup ganda, dikendalikan semu untuk menilai efikasi dan keamanan lampalizumab yang diberikan secara intravitreal kepada pasien dengan atrofi geografis sekunder akibat degenerasi makula terkait usia (GX29176-Roche), Fotografer (Peneliti Utama: Prof. Dr. Nur Kir)

Dipilih sebagai anggota aktif Asosiasi Oftalmologi Turki, Dewan Dokter Muda, 2020 - sekarang

Academic Education:

• Bachelor of Medicine and Surgery. University of Barcelona.
• Doctor in medicine. University of Barcelona. Extraordinary prize for doctoral thesis.
• Training in translational research thanks to a post-doctoral stay at Memorial Sloan-Kettering Cancer Center (New York, USA).

Professional Experience:

• Medical Oncologist specialized in urological cancer. Her areas of expertise are prostate cancer, kidney, bladder and urinary tract cancer, and testicular cancer.
• She currently works as a Senior Consultant in the Medical Oncology Service of the Hospital Clínic de Barcelona, ​​where she is responsible for urological cancer. 
• At HM Delfos, from Medical Oncology, she is responsible for the care of patients with urological cancer, from a multidisciplinary approach in coordination with the different specialists (urology, radiotherapy, pathology) through joint work and the Tumor Committee. She is also responsible for the introduction of new therapies and the development of clinical trial projects in this area.

Scientific and Teaching Activity:

• Associate Professor of the Faculty of Medicine of the Clinical Hospital. University of Barcelona. 
• Teaching in the subject of Medical Oncology, of the 5th year of the Degree in Medicine and Surgery at the University of Barcelona. She has been the director of several Final Degree projects for medical students in ​​urological cancer.
• Teacher and Director of the subject "Prostate Cancer" of the Master of Biomedicine. University of Barcelona.
• Teacher and Director of the subject "Comprehensive management of the uro-oncological patient", of the Master of Uro-Oncology of Advanced Medical Competences. University of Barcelona. 
• Direction of several doctoral theses on prostate cancer.
• Extensive experience in the training of Residents in Medical Oncology at the Clinical Hospital de Barcelona.
• Extensive teaching experience in scientific courses and symposiums.
• Internship tutor for students of the Master in Art Therapy at Escuela Metáfora. Art therapy in cancer patients at Hospital Clinic.
• Coordinator of Mindfulness training workshops in Oncology.
• Clinical research:   Extensive experience as principal investigator of multiple clinical trials, phase I, II and III, of new therapies in urological cancer.
• Translational research: Researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). Leader of the Prostate Cancer working group, within the Translational Genomics Laboratory and Targeted Therapy in Solid Tumors. Her fundamental line of research is based on the investigation of resistance mechanisms to prostate cancer treatments and the study of biomarkers that allow progress towards personalized medicine in this disease.
• She has published more than 140 scientific articles in international journals.

Areas of Professional Interest:

• Her interest as a professional is to provide the best care for patients with urological cancer from all areas: the best care on an individual basis and offer them the best available treatment or the possibility of having access to new treatments within clinical trials. 
• In addition, she has a great interest in promoting comprehensive care for patients and their families.

Associate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:

Breast Cancer

Prostate Cancer

Lung Cancer

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Nichakorn Seehirunwong, M.D.

Radiologist

Graduated (M.D. From)

Doctor of Medicine, Faculty of Medicine, Prince of Songkla University

• Interpreting the results of medical imaging tests.
• Comparing medical image findings with other examinations and tests.
• Consulting with your referring healthcare provider (the provider who ordered the imaging tests) to help choose the proper imaging test and using test results to inform your medical care. Writing reports of results and diagnoses.
• Recommending additional examinations or treatments when necessary.
• Treating diseases by using radiation (radiation oncology) or imaging-guided procedures (interventional radiology). Performing or directing radiology staff to carry out imaging tests.

Certificates

Certificate of Diagnostic Radiology, Faculty of Medicine, Prince of Songkla University

Current Positions

Diagnostic Radiologist at Intrarat Hospital

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Core Specializations

Oncology:

Head and neck tumors

Thyroid cancer

Personalized biological and immunotherapy

Treatment of recurrent cancer and spinal metastases

Radiotherapy

Education

1998 — Graduated from the Faculty of Medicine at the Hebrew University (Jerusalem, Israel).
2016 — Six-month advanced training course in radiosurgery with a special focus on modern methods of focused radiotherapy for spinal and malignant thyroid tumors at Memorial Sloan Kettering Cancer Center (New York, USA).

Professional Experience

1998–1999 — Internship at Hadassah University Hospital (Jerusalem, Israel).
1999–2005 — Specialization in the Department of Otolaryngology and Head & Neck Surgery at Rabin Medical Center (Petah Tikva, Israel).
2005–2009 — Specialization in oncology and radiotherapy at the Davidoff Cancer Center (Rabin Medical Center).
2006–2008 — Fellowship at the University of Michigan (Ann Arbor, USA) in multidisciplinary cancer treatment.
2008 — Fellowship in head and neck tumor brachytherapy at Beth Israel Medical Center (New York, USA).
2009–2012 — Head of the Head and Neck Oncology Clinic at the Davidoff Cancer Center.
2013–2019 — Chief of the Head and Neck Oncology Division and Deputy Head of the Radiotherapy Department at the Davidoff Cancer Center.
Since 2019 — Director of the Oncology Department and Sharett Cancer Institute at Hadassah University Hospital.

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.